@article{1365e524f66f4fab813295346c2c1e3c,
title = "Sleep-Wake Disturbances After Acquired Brain Injury in Children Surviving Critical Care",
abstract = "Background: Sleep-wake disturbances are underevaluated among children with acquired brain injury surviving critical care. We aimed to quantify severity, phenotypes, and risk factors for sleep-wake disturbances. Methods: We performed a prospective cohort study of 78 children aged ≥3 years with acquired brain injury within three months of critical care hospitalization. Diagnoses included traumatic brain injury (n = 40), stroke (n = 11), infectious or inflammatory disease (n = 10), hypoxic-ischemic injury (n = 9), and other (n = 8). Sleep Disturbances Scale for Children standardized T scores measured sleep-wake disturbances. Overall sleep-wake disturbances were dichotomized as any total or subscale T score ≥60. Any T score ≥70 defined severe sleep-wake disturbances. Subscale T scores ≥60 identified sleep-wake disturbance phenotypes. Results: Sleep-wake disturbances were identified in 44 (56%) children and were classified as severe in 36 (46%). Sleep-wake disturbances affected ≥33% of patients within each diagnosis and were not associated with severity of illness measures. The most common phenotype was disturbance in initiation and maintenance of sleep (47%), although 68% had multiple concurrent sleep-wake disturbance phenotypes. One third of all patients had preadmission chronic conditions, and this increased risk for sleep-wake disturbances overall (43% vs 21%, P = 0.04) and in the traumatic brain injury subgroup (52% vs 5%, P = 0.001). Conclusions: Over half of children surviving critical care with acquired brain injury have sleep-wake disturbances. Most of these children have severe sleep-wake disturbances independent of severity of illness measures. Many sleep-wake disturbances phenotypes were identified, but most children had disturbance in initiation and maintenance of sleep. Our study underscores the importance of evaluating sleep-wake disturbances after acquired brain injury.",
keywords = "Brain injury, Critical care outcomes, Pediatric, Sleep, Sleep-wake disorders, Trauma",
author = "Williams, {Cydni N.} and Hartman, {Mary E.} and McEvoy, {Cindy T.} and Hall, {Trevor A.} and Lim, {Miranda M.} and Shea, {Steven A.} and Madison Luther and Guilliams, {Kristin P.} and Guerriero, {Rejean M.} and Bosworth, {Christopher C.} and Piantino, {Juan A.}",
note = "Funding Information: This research was made possible with support from the Oregon Clinical and Translational Research Institute (OCTRI), grant number UL1RR024140 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research. Funding: C.N.W. is supported by the Agency for Healthcare Research and Quality, grant number K12HS022981. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality. C.T.M. is supported by the National Heart, Lung and Blood Institute, R01 HL105447 with cofunding from the Office of Dietary Supplement, R01H L129060 and UG3OD023288. M.M.L. is supported with resources and the use of facilities at the VA Portland Health Care System and VA Career Development Award #IK2 BX002712. Interpretations and conclusions are those of the authors and do not represent the views of the U.S. Department of Veterans Affairs or the United States Government. S.A.S. is supported by the National Institutes of Health, grant numbers R01-HL125893, R01-HL125893-03S1, R01-HL142064, and R01 HL140577, as well as the Oregon Institute of Occupational Health Sciences via funds from the Division of Consumer and Business Services of the State of Oregon (ORS 656.630). K.P.G. is supported by the National Institute of Neurological Disorders and Stroke, grant number K23NS099472. J.A.P. is supported by the National Heart, Lung and Blood Institute, grant number K12HL133115. Conflict of interest and source of funding statement: The authors declare no conflict of interest or financial disclosures concerning the materials or methods used in this study or the findings specified in this article. Funding Information: This research was made possible with support from the Oregon Clinical and Translational Research Institute (OCTRI), grant number UL1RR024140 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research. Funding: C.N.W. is supported by the Agency for Healthcare Research and Quality , grant number K12HS022981. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality. C.T.M. is supported by the National Heart, Lung and Blood Institute, R01 HL105447 with cofunding from the Office of Dietary Supplement, R01H L129060 and UG3OD023288. M.M.L. is supported with resources and the use of facilities at the VA Portland Health Care System and VA Career Development Award #IK2 BX002712. Interpretations and conclusions are those of the authors and do not represent the views of the U.S. Department of Veterans Affairs or the United States Government. S.A.S. is supported by the National Institutes of Health , grant numbers R01-HL125893, R01-HL125893-03S1, R01-HL142064, and R01 HL140577, as well as the Oregon Institute of Occupational Health Sciences via funds from the Division of Consumer and Business Services of the State of Oregon ( ORS 656.630). K.P.G. is supported by the National Institute of Neurologic Disorders and Stroke, grant number K23NS099472. J.A.P. is supported by the National Heart, Lung and Blood Institute, grant number K12HL133115. Publisher Copyright: {\textcopyright} 2019 Elsevier Inc.",
year = "2020",
month = feb,
doi = "10.1016/j.pediatrneurol.2019.08.010",
language = "English (US)",
volume = "103",
pages = "43--51",
journal = "Pediatric Neurology",
issn = "0887-8994",
publisher = "Elsevier Inc.",
}